What is the purpose of this trial?
This is a Phase 3, prospective, open-label, international, multicentre study of Flurpiridaz (18F) Injection for PET MPI in patients referred for ICA because of suspected CAD.
Ages: 18 years and older
NoNO Inc. Krembil Research Institute
Start Date: 11/19/2018
End Date: 04/01/2020
Last Updated: 03/01/2019
Study HIC#: 2000022788